Bright Health Statistics
Share Statistics
Bright Health has 7.98M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 7.98M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,631 |
| FTD / Avg. Volume | 3.29% |
Short Selling Information
The latest short interest is 104.17K, so 1.3% of the outstanding
shares have been sold short.
| Short Interest | 104.17K |
| Short % of Shares Out | 1.3% |
| Short % of Float | 3.47% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.05 and the forward
PE ratio is null.
Bright Health's PEG ratio is
0.
| PE Ratio | -0.05 |
| Forward PE | n/a |
| PS Ratio | 0.05 |
| Forward PS | n/a |
| PB Ratio | 0 |
| P/FCF Ratio | -0.02 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Bright Health.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | 0 |
| Quick Ratio | 0 |
| Debt / Equity | 0 |
| Debt / EBITDA | -0.27 |
| Debt / FCF | -0.11 |
| Interest Coverage | -16.43 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $408,733.1 |
| Profits Per Employee | $-422,746.13 |
| Employee Count | 2,840 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.43M |
| Effective Tax Rate | 0.23% |
Stock Price Statistics
The stock price has increased by 99.15% in the
last 52 weeks. The beta is 0.94, so Bright Health's
price volatility has been higher than the market average.
| Beta | 0.94 |
| 52-Week Price Change | 99.15% |
| 50-Day Moving Average | 8.73 |
| 200-Day Moving Average | 9.58 |
| Relative Strength Index (RSI) | 46.55 |
| Average Volume (20 Days) | 49,602 |
Income Statement
In the last 12 months, Bright Health had revenue of 1.16B
and earned -1.2B
in profits. Earnings per share was -150.94.
| Revenue | 1.16B |
| Gross Profit | -122.92M |
| Operating Income | -627.74M |
| Net Income | -1.2B |
| EBITDA | -1.15B |
| EBIT | -590.97M |
| Earnings Per Share (EPS) | -150.94 |
Full Income StatementBalance Sheet
The company has 466.32M in cash and 303.95M in
debt, giving a net cash position of 162.38M.
| Cash & Cash Equivalents | 466.32M |
| Total Debt | 303.95M |
| Net Cash | 162.38M |
| Retained Earnings | -3.16B |
| Total Assets | 1.23B |
| Working Capital | -302.33M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -2.73B
and capital expenditures -2.9M, giving a free cash flow of -2.73B.
| Operating Cash Flow | -2.73B |
| Capital Expenditures | -2.9M |
| Free Cash Flow | -2.73B |
| FCF Per Share | -343.15 |
Full Cash Flow StatementMargins
Gross margin is -10.59%, with operating and profit margins of -54.08% and -103.43%.
| Gross Margin | -10.59% |
| Operating Margin | -54.08% |
| Pretax Margin | -54.2% |
| Profit Margin | -103.43% |
| EBITDA Margin | -98.68% |
| EBIT Margin | -54.08% |
| FCF Margin | -235.13% |
